SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Pseudo Biologist who wrote (3757)12/19/1997 11:45:00 PM
From: Andrew H  Read Replies (1) | Respond to of 9719
 
>>Dead? How about a recollection of finest and dumbest moments for the biotech investor during 1997? Something in the spirit of best 10 and worst 10 movies. <<

Sounds good to me, but I wonder if we can get the rest of the deadheads on the thread to participate. squelchers??

As for the worst, let's see. CYTO at 6, DEPO at 20, ABTI at 13, LIPO at 25 and CEPH at 28 come immediately to mind. Oh yes, let's not forget VVUS at 39. I am sure there are others.

The finest? Not as easy. IMNX at 20, IDPH at 17, CCSI at 4.

And AGPH seems to deserve a place in both categories. (:>)

What other offerings, folks??

"Non-information" is an interesting term. I guess its pretty much like what we investors get from our biotech companies. (:>)



To: Pseudo Biologist who wrote (3757)1/1/1998 8:10:00 PM
From: squetch  Read Replies (2) | Respond to of 9719
 
How about the little bump that MATX went over this year? It still seems pretty silly to me on FDA's part. Nice catch by WSU.